Published in TB and Outbreaks Week, November 15th, 2005
According to recent research from Finland, "H. pylori is the major cause of chronic gastritis, and a risk factor for peptic ulcer and gastric cancer. To investigate the effect of probiotic supplementation on the tolerance and efficacy of H. pylori eradication treatment in a randomized, double-blind, placebo-controlled trial."
"A total of 338 volunteers were screened for H. pylori infection. The eligibility criteria were met by 47 subjects whose H. pylori infection was verified at the outset and re-evaluated after the treatment...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week